Dr Jonathan Robert Bundy, OD in Missoula, MT - Medicare Optometry Provider

Dr Jonathan Robert Bundy, OD is a medicare enrolled "Optometrist" provider in Missoula, Montana. He went to University Alabama Birmingham - School Of Optometry and graduated in 2007 and has 17 years of diverse experience with area of expertise as Optometry. He is a member of the group practice Matthew R Sullivan Od Pc, Michael Simons P.c. and his current practice location is 726 Kensington Ave, Missoula, Montana. You can reach out to his office (for appointments etc.) via phone at (406) 549-9413.

Dr Jonathan Robert Bundy is licensed to practice in Montana (license number 4917) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1265641203.

Contact Information

	Dr Jonathan Robert Bundy, OD
	726 Kensington Ave, Missoula, MT 59801-5720
	(406) 549-9413
	(406) 543-4410

Healthcare Provider's Profile

Full Name	Dr Jonathan Robert Bundy
Gender	Male
Speciality	Optometry
Experience	17 Years
Location	726 Kensington Ave, Missoula, Montana
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Jonathan Robert Bundy attended and graduated from University Alabama Birmingham - School Of Optometry in 2007

NPI Data:

NPI Number: 1265641203
Provider Enumeration Date: 05/22/2007
Last Update Date: 12/26/2023

Medicare PECOS Information:

PECOS PAC ID: 8527138551
Enrollment ID: I20080603000627

Medical Identifiers

Medical identifiers for Dr Jonathan Robert Bundy such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1265641203	NPI	-	NPPES
331797	Medicaid	AZ

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
152W00000X	Optometrist	S-B55-TA-765 (Alabama)	Secondary
152W00000X	Optometrist	1607 (Arizona)	Secondary
152W00000X	Optometrist	4917 (Montana)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Matthew R Sullivan Od Pc	0749275378	3
Michael Simons P.c.	6901917889	2

News Archive

Steady increase in Low Molecular Weight Heparin use for blood clots: Study

The use of an injectable, clot-preventing drug known as Low Molecular Weight Heparin to treat patients with advanced cancer complicated by blood clots increased steadily between 2000 and 2007, according to a new study published in The Oncologist, funded by the National Cancer Institute and led by Kaiser Permanente Colorado.

Genomatix is among the 41 partners of BLUEPRINT epigenome consortium

Genomatix is among the 41 partners of the BLUEPRINT epigenome consortium funded by the European Commission as a high impact project within its seventh framework program.

Coffe Break campaign by Alzheimer Society to raise funds to support people with dementia

Today the Alzheimer Society gives greater meaning to your daily dose of caffeine. By purchasing a cup of coffee during the Alzheimer Coffee Break(R) fundraiser you will be supporting critical programs and services for the half million Canadians living with Alzheimer's disease or related dementias.

Study of trauma patients evacuated from frontlines provides insight into en route care

A groundbreaking study of nearly 4,000 trauma patients evacuated from the frontlines in Afghanistan over a six-year period offers insight that can inform decisions on team composition, staff training and skill mix on the battlefield and beyond.

Humanetics' BIO 300 medical radiation countermeasure drug candidate issued U.S. patent

In an announcement today, Humanetics Corporation reported that its BIO 300 medical radiation countermeasure drug candidate has been issued a U.S. patent. The patent is assigned to the United States of America with Humanetics as the designated licensee.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Jonathan Robert Bundy allows following entities to bill medicare on his behalf.

Provider Name	Matthew R Sullivan Od Pc
Provider Type	Part B Supplier - Clinic/group Practice
Provider Identifiers	NPI Number: 1285813360 PECOS PAC ID: 0749275378 Enrollment ID: O20040414001843

News Archive

Steady increase in Low Molecular Weight Heparin use for blood clots: Study

Genomatix is among the 41 partners of BLUEPRINT epigenome consortium

Genomatix is among the 41 partners of the BLUEPRINT epigenome consortium funded by the European Commission as a high impact project within its seventh framework program.

Coffe Break campaign by Alzheimer Society to raise funds to support people with dementia

Study of trauma patients evacuated from frontlines provides insight into en route care

Humanetics' BIO 300 medical radiation countermeasure drug candidate issued U.S. patent

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Jonathan Robert Bundy is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Jonathan Robert Bundy, OD 726 Kensington Ave, Missoula, MT 59801-5720 Ph: (406) 549-9413	Dr Jonathan Robert Bundy, OD 726 Kensington Ave, Missoula, MT 59801-5720 Ph: (406) 549-9413

News Archive

Steady increase in Low Molecular Weight Heparin use for blood clots: Study

Genomatix is among the 41 partners of BLUEPRINT epigenome consortium

Genomatix is among the 41 partners of the BLUEPRINT epigenome consortium funded by the European Commission as a high impact project within its seventh framework program.

Coffe Break campaign by Alzheimer Society to raise funds to support people with dementia

Study of trauma patients evacuated from frontlines provides insight into en route care

Humanetics' BIO 300 medical radiation countermeasure drug candidate issued U.S. patent

Optometrist in Missoula, MT

Mark Wayne Mutter Ii, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 700 W Kent Ave, Missoula, MT 59801 Phone: 406-541-3937 Fax: 406-541-3811
Thomas R Ferguson, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2510 S Reserve St, Missoula, MT 59801 Phone: 406-721-5925 Fax: 406-721-3859
Ty William Felton, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2230 N Reserve St Ste 330, Missoula, MT 59808 Phone: 406-309-6633 Fax: 406-309-6644
Dr. Kellie Marie Hadnot, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2106 Oxford St, Missoula, MT 59801 Phone: 406-549-2541
Dr. Heidi Gail Brott, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4000 Us Highway 93 S, Missoula, MT 59804 Phone: 406-251-3679 Fax: 406-251-3715
Shopko Optical 075 Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2510 S Reserve St, Missoula, MT 59801 Phone: 406-721-4646
Sandy Sheppard Od Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 700 South Ave W, Ste. G, Missoula, MT 59801 Phone: 406-549-4851 Fax: 406-549-8486

Dr Jonathan Robert Bundy, OD - Medicare Optometrist in Missoula, MT

Contact Information

Healthcare Provider's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

Steady increase in Low Molecular Weight Heparin use for blood clots: Study

Genomatix is among the 41 partners of BLUEPRINT epigenome consortium

Coffe Break campaign by Alzheimer Society to raise funds to support people with dementia

Study of trauma patients evacuated from frontlines provides insight into en route care

Humanetics' BIO 300 medical radiation countermeasure drug candidate issued U.S. patent

Medicare Reassignments

Steady increase in Low Molecular Weight Heparin use for blood clots: Study

Genomatix is among the 41 partners of BLUEPRINT epigenome consortium

Coffe Break campaign by Alzheimer Society to raise funds to support people with dementia

Study of trauma patients evacuated from frontlines provides insight into en route care

Humanetics' BIO 300 medical radiation countermeasure drug candidate issued U.S. patent

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Steady increase in Low Molecular Weight Heparin use for blood clots: Study

Genomatix is among the 41 partners of BLUEPRINT epigenome consortium

Coffe Break campaign by Alzheimer Society to raise funds to support people with dementia

Study of trauma patients evacuated from frontlines provides insight into en route care

Humanetics' BIO 300 medical radiation countermeasure drug candidate issued U.S. patent

Optometrist in Missoula, MT